Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of ivabradine in patients with stable coronary artery disease without clinical heart failure
2009-011360-10Phase 3Completed
- Sponsor
- Servier
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Ivabradine with Placebo (2 arms). Primary endpoint: Composite of cardiovascular mortality or non-fatal myocardial infarction. Started Aug 2009; status: completed.
02
Drugs
ivabradine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2009-011360-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011360-10.